Evidence map›Paper›PMID 42552620›Full record

ArticleAdvanced healthcare materials2026

Spatiotemporally Programmed Nanofiber Scaffold for Coordinated Hierarchical Multi-Tissue Regeneration in Pressure Ulcers.

Fan Zhang, Xindan Zhang, Hongtao Hu, Jianfeng Tong, Yonglai Lu, Jian Xiao, Jiao Jiao Li, Jiajia Xue

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fan ZhangBeijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, China.ORCID https://orcid.org/0009-0000-4665-2467
Xindan ZhangBeijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, China.ORCID https://orcid.org/0009-0004-5437-5016
Hongtao HuBeijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, China.ORCID https://orcid.org/0009-0004-7133-7417
Jianfeng TongBeijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, China.ORCID https://orcid.org/0000-0001-5706-576X
Yonglai LuBeijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, China.ORCID https://orcid.org/0000-0002-6651-1116
Jian XiaoDepartment of Wound healing, The First Affiliated Hospital of Wenzhou Medical University, Oujiang Laboratory (Zhejiang Lab For Regenerative Medicine, Vision and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China.
Jiao Jiao LiSchool of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Sydney, NSW, Australia.ORCID https://orcid.org/0000-0002-3584-6765
Jiajia XueBeijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing, China.ORCID https://orcid.org/0000-0002-7209-7935

Funding

Beijing High-Level Innovation and Entrepreneurship Talent Support Program 202504841018Fundamental Research Funds for the Central Universities buctrc202020Interdisciplinary Research Center of Beijing University of Chemical Technology XK2025-05National Key Research and Development Program of China 2022YFC2408200National Natural Science Foundation of China 52221006;52473121;52588201Rebecca L Cooper Medical Research Foundation N/A
6 · The paper itself

Abstract

Stage IV pressure ulcers (PUs) represent the most severe form of chronic wounds, involving full-thickness damage to skin, vasculature, nerves, and muscle, and remain difficult to treat due to the need for coordinated multi-tissue regeneration. Here, we develop a nanofiber scaffold that orchestrates multimodal tissue repair through the integration of biophysical guidance and spatiotemporally controlled biochemical signaling. The scaffold features a sandwich-structured architecture composed of poly(ε-caprolactone) (PCL) nanofibrous layers with distinct functions. A radially aligned, wound-facing layer is functionalized with a center-increasing gradient of keratinocyte growth factor 2-loaded collagen nanoparticles, enabling rapid diffusion-driven delivery to accelerate early re-epithelialization. The outer layer comprises randomly oriented PCL nanofibers, ensuring mechanical support and structural stability. Between these layers, phase-change material microparticles co-encapsulating basic fibroblast growth factor and indocyanine green enable near-infrared-triggered, on-demand release, sustaining local bFGF availability to support vascular reconstruction and subsequent muscle regeneration. This temporally coordinated delivery strategy couples early-stage epidermal repair with prolonged support for deeper tissue regeneration. In a rat stage IV PU model, the scaffold accelerates wound closure and promotes coordinated regeneration of multiple tissue components, outperforming clinically used wound dressings. Collectively, this work establishes a nanofiber-based strategy for spatiotemporally orchestrated tissue regeneration in severe wounds.

Indexed as

NanofibersPressure UlcerRegenerationTissue ScaffoldsAnimalsFibroblast Growth Factor 2PolyestersRatsRats, Sprague-DawleyWound HealingFibroblast Growth Factor 2polycaprolactonePolyestersgrowth factor gradientnanofiber scaffoldNIR‐triggered releasepressure ulcer repairradially aligned nanofiberswound healing

Identifiers

PMID42552620
PMCPMC13542969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.